Noriega, Fortunata M.
HRN: 18-14-78 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/27/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
09/27/2022
10/03/2022
IVT
1.5g
Q6
CAP
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes